Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms.
Felizardo RJF, de Almeida DC, Pereira RL, Watanabe IKM, Doimo NTS, Ribeiro WR, Cenedeze MA, Hiyane MI, Amano MT, Braga TT, Ferreira CM, Parmigiani RB, Andrade-Oliveira V, Volpini RA, Vinolo MAR, Mariño E, Robert R, Mackay CR, Camara NOS.
Felizardo RJF, et al. Among authors: marino e.
FASEB J. 2019 Nov;33(11):11894-11908. doi: 10.1096/fj.201901080R. Epub 2019 Jul 31.
FASEB J. 2019.
PMID: 31366236
B., Andrade-Oliveira, V., Volpini, R. A., Vinolo, M. A. R., Marino, E., Robert, R., Mackay, C. R., Camara, N. O. S. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms....
B., Andrade-Oliveira, V., Volpini, R. A., Vinolo, M. A. R., Marino, E., Robert, R., Mackay, C. R., Camara, N. O. S. Gut microb …